Key result
MRI correlates with 2dE for septal thickness but alters hypertrophy assessment in ~22% of patients.
Why the study?
The diagnostic role of MRI compared with two-dimensional and Doppler echocardiography in hypertrophic cardiomyopathy was evaluated.
Does MRI provide comparable or additional diagnostic information compared to 2dE and Doppler echocardiography in patients with hypertrophic cardiomyopathy?
Observational (n=23)
Does MRI provide comparable or additional diagnostic information compared to 2dE and Doppler echocardiography in patients with hypertrophic cardiomyopathy?
Effect estimate: r = 0.930
p-value: p=< 0.01
MRI provides valuable morphologic and functional diagnostic information in hypertrophic cardiomyopathy, correlating well with echocardiography while potentially altering the assessment of hypertrophy distribution.
No takes yet. Share an insight, caveat, or question.
MRI may complement 2dE in HCM assessment; leaves open whether distribution changes alter management without prospective data.
Sardanelli et al. (1993) conducted an observational in Hypertrophic cardiomyopathy (n=23). Magnetic resonance imaging (MRI) vs. Two-dimensional echocardiography (2dE) and Doppler echocardiography was evaluated on Correlation of septal wall thickness between MRI and 2dE (r = 0.930, p=< 0.01). Magnetic resonance imaging showed excellent correlation with 2dE for septal wall thickness (r = 0.930, p < 0.01) and altered the assessment of hypertrophy distribution in 5 of 23 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: